Subscription Agreement Number: May 1, 2017 Issued to: in connection with the Offering by Digital Power Corporation ofSubscription Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 Jurisdiction
Subscription Agreement Number: Issued to:Subscription Agreement • April 16th, 2018 • Mateon Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 16th, 2018 Company Industry JurisdictionThis Subscription Agreement (this “Subscription Agreement”) is being delivered to the purchaser identified on the signature page to this Agreement (the “Undersigned” or “Subscriber”) in connection with its investment in the securities of Mateon Therapeutics, Inc., a Delaware corporation (the “Company”). The Company is conducting a private placement (the “Offering”) of a minimum of 20 and a maximum of 80 Units, each of which consists of 250,000 shares of Common Stock of the Company, $0.01 par value per share (the “Common Stock”), and warrants (the “A Warrants”) to purchase 125,000 shares of Common Stock at an exercise price of $0.40 per share and warrants (the “B Warrants”) to purchase 125,000 shares of Common Stock at an exercise price of $0.40 per share (collectively, the “Warrants”), at $50,000 per Unit (a “Unit”). For purposes of this Agreement, the term “Securities” shall refer to the Units, the Common Stock, the Warrants and the Common Stock to be issued upon the exercise of the W
Subscription Agreement Number: May 1, 2017 Issued to:Subscription Agreement • May 31st, 2017 • Digital Power Corp • Electronic components, nec • New York
Contract Type FiledMay 31st, 2017 Company Industry JurisdictionThis Subscription Agreement (this “Subscription Agreement”) is being delivered to the purchaser identified on the signature page to this Agreement (the “Subscriber”) in connection with its investment in the securities of Digital Power Corporation, a California corporation (the “Company”). The Company is conducting a private placement (the “Offering”) of a minimum of four Units and a maximum of 21 Units ($1,096,000) at a purchase price of $52,000 per Unit (the “Purchase Price”) with each Unit consisting of (i) 26,666 shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”), which each share will be convertible into four shares of the Company’s common stock (the “Common Stock,”) and (ii) five year warrants (“Warrants”) providing the holder thereof the right to acquire in the aggregate 86,667 shares of Common Stock (collectively, the “Warrant Shares”) at an exercise price of $1.00 per share. For purposes of this Agreement, the term “Securities” shall refer to the Units,